SCHEMBL25516265

SCHEMBL25516265

CC(=N)c1cc(C(=O)NN)ccc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
MPO P05164 2/20 0.43
CYP3A4 P08684 2/20 0.43
BLM P54132 2/20 0.43
KDM5A P29375 1/20 0.43
GFER P55789 1/20 0.43
PMP22 Q01453 1/20 0.43
HIF1A Q16665 1/20 0.43
MYC P01106 1/20 0.42
KDM4E B2RXH2 8/20 0.42
ALDH1A1 P00352 5/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
LMNA P02545 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
OGG1 O15527 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
LRRK2 Q5S007 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25516110 0.81 KDM4E (0.41) MAPTBLMGFERKDM4EALDH1A1
SCHEMBL13522728 0.81 CDC25B (0.49) MAPTBLMGFERKDM4EALDH1A1
SCHEMBL24633560 0.80 ALDH1A1 (0.44) MAPTKDM4EALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL22489533 0.80 ALDH1A1 (0.60) MAPTKDM4EALDH1A1CA1CA2
SCHEMBL20217344 0.80 ALDH1A1 (0.53) KDM4EALDH1A1LMNAL3MBTL1HDAC1
SCHEMBL22452996 0.77 LRRK2 (0.50) MAPTKDM4ELMNAHDAC1HDAC6
SCHEMBL20217275 0.77 KIT (0.53) KDM4EALDH1A1CA2HDAC6HPGD
SCHEMBL1252657 0.76 MPO (0.54) MAPTMPOCYP3A4BLMKDM5A
SCHEMBL29803197 0.76 MPO (0.54) MAPTMPOCYP3A4BLMKDM5A
SCHEMBL20217243 0.76 KDM4E (0.51) KDM4EALDH1A1LMNAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023078337-A1 CDK8/19 DUAL INHIBITORS AND METHODS OF USE INSILICO MEDICINE IP LIMITED (CN) 2023-05-11 WO disclosed